These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 11237208)

  • 1. Protein glycation, diabetes, and aging.
    Ulrich P; Cerami A
    Recent Prog Horm Res; 2001; 56():1-21. PubMed ID: 11237208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes.
    Aronson D
    J Hypertens; 2003 Jan; 21(1):3-12. PubMed ID: 12544424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
    Vasan S; Zhang X; Zhang X; Kapurniotu A; Bernhagen J; Teichberg S; Basgen J; Wagle D; Shih D; Terlecky I; Bucala R; Cerami A; Egan J; Ulrich P
    Nature; 1996 Jul; 382(6588):275-8. PubMed ID: 8717046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of breakers of advanced glycation end product-protein crosslinks.
    Vasan S; Foiles P; Founds H
    Arch Biochem Biophys; 2003 Nov; 419(1):89-96. PubMed ID: 14568012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting advanced glycation with pharmaceutical agents: where are we now?
    Borg DJ; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):653-70. PubMed ID: 27392438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.
    Chellan P; Nagaraj RH
    Arch Biochem Biophys; 1999 Aug; 368(1):98-104. PubMed ID: 10415116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation endproducts and cigarette smoking.
    Nicholl ID; Bucala R
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1025-33. PubMed ID: 9846884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical intervention of advanced glycation endproducts.
    Cerami A; Ulrich P
    Novartis Found Symp; 2001; 235():202-12; discussion 212-6, 217-20. PubMed ID: 11280026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosslink breakers: a new approach to cardiovascular therapy.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Curr Opin Cardiol; 2004 Jul; 19(4):336-40. PubMed ID: 15218393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.
    Bierhaus A; Hofmann MA; Ziegler R; Nawroth PP
    Cardiovasc Res; 1998 Mar; 37(3):586-600. PubMed ID: 9659442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation endproducts and diabetes. Beyond vascular complications.
    Puddu A; Viviani GL
    Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):132-40. PubMed ID: 21476962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats.
    Yang S; Litchfield JE; Baynes JW
    Arch Biochem Biophys; 2003 Apr; 412(1):42-6. PubMed ID: 12646266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Maillard reaction in diabetes mellitus and diseases of aging.
    Thorpe SR; Baynes JW
    Drugs Aging; 1996 Aug; 9(2):69-77. PubMed ID: 8820792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.
    Babizhayev MA; Deyev AI; Savel'yeva EL; Lankin VZ; Yegorov YE
    J Dermatolog Treat; 2012 Oct; 23(5):345-84. PubMed ID: 21756141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease.
    Zieman SJ; Kass DA
    Drugs; 2004; 64(5):459-70. PubMed ID: 14977384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
    Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
    Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-products: Mechanics of aged collagen from molecule to tissue.
    Gautieri A; Passini FS; Silván U; Guizar-Sicairos M; Carimati G; Volpi P; Moretti M; Schoenhuber H; Redaelli A; Berli M; Snedeker JG
    Matrix Biol; 2017 May; 59():95-108. PubMed ID: 27616134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products: a Nephrologist's perspective.
    Raj DS; Choudhury D; Welbourne TC; Levi M
    Am J Kidney Dis; 2000 Mar; 35(3):365-80. PubMed ID: 10692262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications.
    Sensi M; Pricci F; Andreani D; Di Mario U
    Diabetes Res; 1991 Jan; 16(1):1-9. PubMed ID: 1818791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins.
    Nagaraj RH; Monnier VM
    Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.